Effects of carbamazepine and metabolites on IL-2, IL-5, IL-6, IL-10 and IFN-γ secretion in epileptic patients: the influence of co-medication.

Journal Title: Pharmacological Reports - Year 2011, Vol 63, Issue 1

Abstract

Carbamazepine is a widely used anticonvulsive agent. Its metabolic pathway leads not only to the major active metabolite, carbamazepine-10,11-epoxide, but also to minor terminal metabolites such as iminostilbene and acridine. Carbamazepine is usually well-tolerated, but it may lead to rare, but serious, hypersensitive reactions associated with hypereosinophilia. The mechanisms of hypersensitivity reactions to carbamazepine are still largely unknown, and the implications of the cell-mediated immune response (Th1 pathway) or the humoral immune response (Th2 pathway) are still not understood in these reactions. It is also unclear whether the parent drug or its subsequent metabolites are the primary trigger agent. In our study, we performed ex vivo experiments to evaluate the stimulation of cytokine secretion by carbamazepine, carbamazepine-10,11-epoxide, iminostilbene and acridine. IL-5, IL-6 and IL-10 were quantified as markers of the Th2 pathway, and IL-2 and IFN-γ were used as markers of the Th1 pathway. Blood samples (n=24) were obtained from epileptic patients routinely treated with carbamazepine alone or co-treated with lamotrigine or valproate. The concentrations of cytokines in the plasma were determined before and after 3 h stimulation with drugs. We found a significantly positive effect of co-treatment with valproate on the basal level of IL-5 (p<0.01) and IL-10 (p<0.05). IL-5 production increased only in blood stimulated with a high level of acridine (33 μM), whereas IL-6 production was less specifically stimulated (p<0.05). Because IL-5 is the most potent stimulating factor of the eosinophils, we suggest that the potential helper effect of valproate and acridine can lead to hypersensitive reactions to carbamazepine in the context of the humoral immune response.

Authors and Affiliations

Olivier Mathieu, Marie-Christine Picot, Philippe Gelisse, Hélène Breton, Pascal Demoly, Dominique Hillaire-Buys

Keywords

Related Articles

LPS-induced oxidative stress and inflammatory reaction in the rat striatum.

Inflammation-induced microglia activation and increased oxidative stress have been observed in neurodegenerative disorders, such as Parkinson's disease. The aim of our study was to determine the appropriate dose and rout...

Flutamide treatment induces anxiolytic-like behavior in adult castrated rats.

Background: It has previously been speculated that the androgen receptor antagonist flutamide produces behavioral effects that are not mediated by androgen receptors. These earlier studies were performed in intact rodent...

Hypertriglyceridemia but not hypercholesterolemia induces endothelial dysfunction in the rat.

In humans, hypercholesterolemia and hypertriglyceridemia induce endothelial dysfunction and therefore lead to atherosclerosis. In contrast, rats are resistant to atherosclerosis. Here we analyze whether rats respond to h...

Differential effects of genistein, estradiol and raloxifene on rat osteoclastsin vitro.

Genistein, a major phytoestrogen of soy, is considered a potential drugfor prevention and treatment of postmenopausal osteoporosis. It is not clear whether mechanism of actionof genistein on bone turnover is distinct fro...

5-HT-induced depression of the spinal monosynaptic reflex potential utilizes different types of 5-HT receptors depending on Mg2+ availability.

Receptor subtypes involved in the 5-hydroxytryptamine (5-HT)-induced depression of synaptic transmission in neonatal rat spinal cords in vitro were evaluated in the absence or presence of Mg(2+) in the medium. Stimulatio...

Download PDF file
  • EP ID EP129499
  • DOI -
  • Views 87
  • Downloads 0

How To Cite

Olivier Mathieu, Marie-Christine Picot, Philippe Gelisse, Hélène Breton, Pascal Demoly, Dominique Hillaire-Buys (2011). Effects of carbamazepine and metabolites on IL-2, IL-5, IL-6, IL-10 and IFN-γ secretion in epileptic patients: the influence of co-medication.. Pharmacological Reports, 63(1), 86-94. https://europub.co.uk./articles/-A-129499